1. Home
  2. ITRM vs HIT Comparison

ITRM vs HIT Comparison

Compare ITRM & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • HIT
  • Stock Information
  • Founded
  • ITRM 2015
  • HIT 1964
  • Country
  • ITRM Ireland
  • HIT United States
  • Employees
  • ITRM N/A
  • HIT N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • HIT Specialty Insurers
  • Sector
  • ITRM Health Care
  • HIT Finance
  • Exchange
  • ITRM Nasdaq
  • HIT Nasdaq
  • Market Cap
  • ITRM 40.0M
  • HIT 37.2M
  • IPO Year
  • ITRM 2018
  • HIT 2024
  • Fundamental
  • Price
  • ITRM $1.01
  • HIT $0.80
  • Analyst Decision
  • ITRM Strong Buy
  • HIT Strong Buy
  • Analyst Count
  • ITRM 2
  • HIT 1
  • Target Price
  • ITRM $7.00
  • HIT $2.50
  • AVG Volume (30 Days)
  • ITRM 481.0K
  • HIT 261.7K
  • Earning Date
  • ITRM 08-13-2025
  • HIT 08-15-2025
  • Dividend Yield
  • ITRM N/A
  • HIT N/A
  • EPS Growth
  • ITRM N/A
  • HIT N/A
  • EPS
  • ITRM N/A
  • HIT 0.02
  • Revenue
  • ITRM N/A
  • HIT $22,380,959.00
  • Revenue This Year
  • ITRM N/A
  • HIT $58.79
  • Revenue Next Year
  • ITRM $270.19
  • HIT N/A
  • P/E Ratio
  • ITRM N/A
  • HIT $45.15
  • Revenue Growth
  • ITRM N/A
  • HIT 11.24
  • 52 Week Low
  • ITRM $0.81
  • HIT $0.51
  • 52 Week High
  • ITRM $3.02
  • HIT $7.59
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 51.14
  • HIT N/A
  • Support Level
  • ITRM $0.93
  • HIT N/A
  • Resistance Level
  • ITRM $1.06
  • HIT N/A
  • Average True Range (ATR)
  • ITRM 0.05
  • HIT 0.00
  • MACD
  • ITRM 0.01
  • HIT 0.00
  • Stochastic Oscillator
  • ITRM 34.78
  • HIT 0.00

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

Share on Social Networks: